BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27813876)

  • 1. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
    Khotskaya YB; Mills GB; Mills Shaw KR
    Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology as basis for timely cancer diagnosis and therapy.
    Mackinnon AC; Chandrashekar DS; Suster DI
    Virchows Arch; 2024 Feb; 484(2):155-168. PubMed ID: 38012424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice.
    Hicks JK; Howard R; Reisman P; Adashek JJ; Fields KK; Gray JE; McIver B; McKee K; O'Leary MF; Perkins RM; Robinson E; Tandon A; Teer JK; Markowitz J; Rollison DE
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34095711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of "clinical sequencing" in cancer genome medicine in Japan.
    Kohno T
    Cancer Sci; 2018 Mar; 109(3):507-512. PubMed ID: 29285848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
    Zolotovskaia MA; Sorokin MI; Petrov IV; Poddubskaya EV; Moiseev AA; Sekacheva MI; Borisov NM; Tkachev VS; Garazha AV; Kaprin AD; Shegay PV; Giese A; Kim E; Roumiantsev SA; Buzdin AA
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
    Trapani D; Crimini E; Sandoval J; Curigliano G
    Cancer Treat Res; 2023; 188():343-351. PubMed ID: 38175352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding inequities in precision oncology diagnostics.
    Dutta R; Vallurupalli M; McVeigh Q; Huang FW; Rebbeck TR
    Nat Cancer; 2023 Jun; 4(6):787-794. PubMed ID: 37248397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
    Vingiani A; Agnelli L; Duca M; Lorenzini D; Damian S; Proto C; Niger M; Nichetti F; Tamborini E; Perrone F; Piccolo A; Manoukian S; Azzollini J; Brambilla M; Colombo E; Lopez S; Vernieri C; Marra F; Conca E; Busico A; Capone I; Bozzi F; Angelini M; Devecchi A; Salvatori R; De Micheli V; Baggi A; Pasini S; Jommi C; Ladisa V; Apolone G; De Braud F; Pruneri G
    JCO Precis Oncol; 2023 Jul; 7():e2300067. PubMed ID: 37487147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.
    Murciano-Goroff YR; Drilon A; Stadler ZK
    Cancer Cell; 2021 Jan; 39(1):22-24. PubMed ID: 33434511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant allele frequency: a decision-making tool in precision oncology?
    Boscolo Bielo L; Trapani D; Repetto M; Crimini E; Valenza C; Belli C; Criscitiello C; Marra A; Subbiah V; Curigliano G
    Trends Cancer; 2023 Dec; 9(12):1058-1068. PubMed ID: 37704501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Realizing the Dream of Precision Oncology: A Solution for All Patients.
    Zhou Y
    J Mol Diagn; 2023 Dec; 25(12):851-856. PubMed ID: 37748706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring Progress in Precision Oncology.
    Horak P; Fröhling S
    Cancer Discov; 2024 Jan; 14(1):18-19. PubMed ID: 38213297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular tumour boards - current and future considerations for precision oncology.
    Tsimberidou AM; Kahle M; Vo HH; Baysal MA; Johnson A; Meric-Bernstam F
    Nat Rev Clin Oncol; 2023 Dec; 20(12):843-863. PubMed ID: 37845306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.
    Zhang X; Liang Z; Wang S; Lu S; Song Y; Cheng Y; Ying J; Liu W; Hou Y; Li Y; Liu Y; Hou J; Liu X; Shao J; Tai Y; Wang Z; Fu L; Li H; Zhou X; Bai H; Wang M; Lu Y; Yang J; Zhong W; Zhou Q; Yang X; Wang J; Huang C; Liu X; Zhou X; Zhang S; Tian H; Chen Y; Ren R; Liao N; Wu C; Zhu Z; Pan H; Gu Y; Wang L; Liu Y; Zhang S; Liu T; Chen G; Shao Z; Xu B; Zhang Q; Xu R; Shen L; Wu Y; Tumor Biomarker Committee OBOCSOCOC
    Cancer Biol Med; 2019 Feb; 16(1):189-204. PubMed ID: 31119060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus Statements on Precision Oncology in the China Greater Bay Area.
    Lam TC; Cho WC; Au JS; Ma ES; Lam ST; Loong HH; Wong JWH; Wong SNM; Lee VH; Leung RC; Lau JK; Kam MT; Mok FS; Lim FM; Nyaw JS; Tin WW; Cheung KM; Chan OS; Kwong PW; Cheung FY; Poon DMC; Chik JY; Lam MH; Chan LW; Wong SC; Cao YB; Hui CV; Chen JZ; Chang JH; Kong SF; El Helali A;
    JCO Precis Oncol; 2023 Jun; 7():e2200649. PubMed ID: 37315266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing Clinically Significant Lung Cancer Somatic Mutations for Targeted Therapy Through Efficient NGS Data Filtering System.
    Wang J; Li H; Liu H
    AMIA Jt Summits Transl Sci Proc; 2024; 2024():305-313. PubMed ID: 38827108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings.
    Horne HN; Roscoe D; Litwack ED; Pathak A; Pandey JP; Gallagher PS; Koontz LM; Schuck RN; Lee EY; Hu YF; Beaver JA; Blumenthal GM; Philip R
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.
    Zeng J; Johnson A; Shufean MA; Kahle M; Yang D; Woodman SE; Vu T; Moorthy S; Holla V; Meric-Bernstam F
    JCO Clin Cancer Inform; 2019 Sep; 3():1-12. PubMed ID: 31550176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supporting the decision to perform molecular profiling for cancer patients based on routinely collected data through the use of machine learning.
    Kasprzak J; Westphalen CB; Frey S; Schmitt Y; Heinemann V; Fey T; Nasseh D
    Clin Exp Med; 2024 Apr; 24(1):73. PubMed ID: 38598013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities in building a health economic framework for personalized medicine in oncology.
    Aguiar PN; Matsas S; Dienstmann R; Ferreira CG
    Per Med; 2023 Sep; 20(5):453-460. PubMed ID: 37602420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.